Intellia Therapeutics NTLA
NASDAQ NTLA
$11.41 +0.24 (+2.15%)
As of: Nov 11, 2026 · 3:59 PM EST

Intellia Therapeutics (NTLA) Goodwill (2015 - 2017)

Updated

Analysis

Intellia Therapeutics (NTLA) Goodwill (2015 - 2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Intellia Therapeutics 1.57 Bn -171.10 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 421.71 Mn
Dec 31, 2016 263.40 Mn
Dec 31, 2015 88.56 Mn
API Access

Intellia Therapeutics Goodwill API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=goodwill&ticker=NTLA&period=max&api_key=YOUR_API_KEY